OLFC Introduces New NOXO Sensory Spectrum Disorders Gel(TM) that Could End or Help Meltdowns
PHILADELPHIA, PA / ACCESSWIRE / August 23, 2017 / Olfactory Biosciences Corp. (OTC PINK: OLFC) is pleased to announce new NOXO Sensory Spectrum Disorders Gel™.
Sensory Meltdowns are Neurological. A child with sensory processing disorder or autism may find that meltdowns are eliminated with NOXO Sensory Spectrum Disorders Gel™, or it has helped improve behavior and social engagement.
New NOXO Sensory Spectrum Disorders Gel™ contains therapeutic natural ingredients, which are delivered to the brain via the olfactory receptors after topical application under the nose. Once NOXO Sensory Spectrum Disorders Gel™ is inhaled, the NOXO molecules transport their "messages" directly to the brain's emotional center - the limbic system, and there is an improvement in sensory messaging processing. https://goo.gl/SvAwP7
Ingredients: A special proprietary formulation of Phytonutrients and Phytochemicals taken from plants, flowers, roots, and seeds. All ingredients are in a soy base which is FDA approved for cosmetic use. The specific chemical identities of the ingredients in this mixture are considered by us to be trade secrets and are withheld in accordance with the provisions of the 1910.1200 of the Code of Federal Regulations.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.